DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 159 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2018. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $263,000 | -18.8% | 36,011 | +1.6% | 0.00% | -50.0% |
| Q4 2018 | $324,000 | -27.5% | 35,437 | -1.7% | 0.00% | 0.0% |
| Q3 2018 | $447,000 | -18.6% | 36,053 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $549,000 | -21.9% | 36,053 | +1.7% | 0.00% | -40.0% |
| Q1 2018 | $703,000 | +6.0% | 35,437 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $663,000 | -72.5% | 35,437 | -68.4% | 0.00% | -76.5% |
| Q3 2017 | $2,414,000 | – | 112,260 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |